Advancing Personalized Cancer Medicine Through Research
- COMING SOON ! 10X Genomics Chromium Single Cell Sequencing Platform!
- Newest CPCT faculty member, Shailja Pathania PhD, seeks new clues to hereditary breast cancer. (posted 3/30/17)
- Click here for past announcements.
The Center for Personalized Cancer Therapy (CPCT) Genomics Core enables UMass Boston investigators and academic and industry collaborators to carry out basic and translational genomics research, leveraging cutting-edge technologies and next-generation sequencing capabilities for research and clinical applications. The Genomics Core helps investigators and clinicians analyze samples, identify genetic variants contributing to disease risk, and reveal complex mechanisms involved in human disease.